Literature DB >> 14974914

Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.

Dewi Astuti1, Niki Hart-Holden, Farida Latif, Fiona Lalloo, Graeme C Black, Caron Lim, Anthony Moran, Ashley B Grossman, Shirley V Hodgson, Anthony Freemont, Richard Ramsden, Charis Eng, D Gareth R Evans, Eamonn R Maher.   

Abstract

BACKGROUND: Germline mutations in three subunits of mitochondrial complex II (SDHB, SDHC and SDHD) may be associated with susceptibility to phaeochromocytoma (PC) and/or head and neck paraganglioma (HNPGL).
METHODS: To further define the role of SDH subunit mutations in these disorders, we analysed a series of 22 probands with PC and evidence of genetic susceptibility (seven with familial PC only, one with familial PC and HNPGL, 10 sporadic cases with multiple PC and four cases of isolated paediatric onset PC) for germline SDHB, SDHC and SDHD mutations. In addition, we analysed 34 cases of HNPGL (30 isolated cases with single tumours, three isolated cases with multiple tumours and one familial case with multiple tumours) for somatic and germline mutations in SDHB, SDHC and SDHD.
RESULTS: We identified four germline mutations (three SDHB and one SDHD, three novel) in the 22 PC probands. Combining these results with our previous series, we have detected germline SDHB or SDHD mutations in 2/12 (17%) of familial PC only kindreds, 4/5 (80%) of familial PC and HNPGL cases, 1/10 of sporadic multiple PC cases and 2/4 (50%) of paediatric PCs. No somatic mutations were detected in the HNPGL tumours, but four cases with multiple HNPGL had the common P81L germline SDHD mutation. Intriguingly a silent SNP (c.204C > T) in SDHD was significantly more common in HNPGL cases (6/34) than in controls (1/100, P = 0.0011). Combining our results with those from two other large studies in which both SDHB and SDHD have been analysed, SDHB mutations were most commonly associated with phaeochromocytoma susceptibility and SDHD with the development of HNPGL (P = 0.025). However, germline SDHB and SDHD mutations demonstrate considerable phenotypic variability and genotype-phenotype correlations are complex.
CONCLUSION: The significantly lower frequency (P = 0.028) of germline SDH subunit mutations in familial PC only cases compared to those with familial PC and HNPGL suggests that further PC susceptibility gene(s) remain to be identified.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14974914     DOI: 10.1046/j.1365-2265.2003.01914.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  32 in total

1.  Comparative analysis of some aspects of mitochondrial metabolism in differentiated and undifferentiated neuroblastoma cells.

Authors:  Aleksandr Klepinin; Vladimir Chekulayev; Natalja Timohhina; Igor Shevchuk; Kersti Tepp; Andrus Kaldma; Andre Koit; Valdur Saks; Tuuli Kaambre
Journal:  J Bioenerg Biomembr       Date:  2013-09-27       Impact factor: 2.945

Review 2.  Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma.

Authors:  Ales Vicha; David Taieb; Karel Pacak
Journal:  Endocr Relat Cancer       Date:  2014-05-08       Impact factor: 5.678

Review 3.  Primary Mitochondrial Disease and Secondary Mitochondrial Dysfunction: Importance of Distinction for Diagnosis and Treatment.

Authors:  Dmitriy M Niyazov; Stephan G Kahler; Richard E Frye
Journal:  Mol Syndromol       Date:  2016-06-03

Review 4.  Signaling pathways in pheochromocytomas and paragangliomas: prospects for future therapies.

Authors:  Svenja Nölting; Ashley B Grossman
Journal:  Endocr Pathol       Date:  2012-03       Impact factor: 3.943

5.  Combined blockade of signalling pathways shows marked anti-tumour potential in phaeochromocytoma cell lines.

Authors:  Svenja Nölting; Edwin Garcia; Ghassan Alusi; Alessio Giubellino; Karel Pacak; Márta Korbonits; Ashley B Grossman
Journal:  J Mol Endocrinol       Date:  2012-07-25       Impact factor: 5.098

6.  Impact of screening kindreds for SDHD p.Cys11X as a common mutation associated with paraganglioma syndrome type 1.

Authors:  Mariola Peczkowska; Zoran Erlic; Michael M Hoffmann; Mariusz Furmanek; Jaroslaw Cwikla; Agata Kubaszek; Aleksander Prejbisz; Zbigniew Szutkowski; Andrzej Kawecki; Krzysztof Chojnowski; Anna Lewczuk; Mieczyslaw Litwin; Witold Szyfter; Martin A Walter; Maren Sullivan; Charis Eng; Andrzej Januszewicz; Hartmut P H Neumann
Journal:  J Clin Endocrinol Metab       Date:  2008-09-30       Impact factor: 5.958

7.  Familial paragangliomas.

Authors:  Cjm Lips; Egwm Lentjes; Jwm Höppener; Rb van der Luijt; Fl Moll
Journal:  Hered Cancer Clin Pract       Date:  2006-10-15       Impact factor: 2.857

8.  Penetrance and clinical consequences of a gross SDHB deletion in a large family.

Authors:  D C Solis; N Burnichon; H J L M Timmers; M J Raygada; A Kozupa; M J Merino; D Makey; K T Adams; A Venisse; A-P Gimenez-Roqueplo; K Pacak
Journal:  Clin Genet       Date:  2009-04       Impact factor: 4.438

9.  Human pheochromocytomas show reduced p27Kip1 expression that is not associated with somatic gene mutations and rarely with deletions.

Authors:  Natalia S Pellegata; Leticia Quintanilla-Martinez; Gisela Keller; Sandya Liyanarachchi; Heinz Höfler; Michael J Atkinson; Falko Fend
Journal:  Virchows Arch       Date:  2007-06-07       Impact factor: 4.064

Review 10.  Components of cancer metabolism and therapeutic interventions.

Authors:  John Singleterry; Annapoorna Sreedhar; Yunfeng Zhao
Journal:  Mitochondrion       Date:  2014-06-06       Impact factor: 4.160

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.